GliaPharm

GliaPharm is a biotechnology company that develops a new class of medicines targeting glial cells to treat neurological disorders. The company utilizes its GliaX technology platform to discover drugs that target glia-mediated pathways for neuroprotection and the maintenance of cognitive functions. Its research focuses on the metabolic support and homeostatic roles of astrocytes to address brain health globally.